Literature DB >> 6419740

Two genetically different MU-NANA neuraminidases in human leucocytes.

F W Verheijen, H C Janse, O P van Diggelen, H D Bakker, M C Loonen, P Durand, H Galjaard.   

Abstract

Human leucocytes contain two different MU-NANA neuraminidases, which can be distinguished by Concanavalin A binding. The Con A binding form is predominant in lymphocytes (more than 80%) and the non-binding form predominates in granulocytes. The pH optima of both these neuraminidases as well as their subcellular localization as determined by Percoll gradient centrifugation suggest that they are both lysosomal. Immunological studies indicate that the Con A binding form is present in a complex with beta-galactosidase whereas the non-binding form is not. Leucocytes from patients with sialidosis or galactosialidosis are deficient in the Con A binding neuraminidase, whereas the non-binding form is normal. In sialolipidosis both forms are normal. These results demonstrate that leucocytes contain at least two genetically different MU-NANA neuraminidases. Thus, the use of leucocytes should be avoided for the diagnosis of sialidosis and galactosialidosis, and isolated lymphocytes should be used to obtain reliable results.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6419740     DOI: 10.1016/0006-291x(83)91224-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Mobilization of sialidase from intracellular stores to the surface of human neutrophils and its role in stimulated adhesion responses of these cells.

Authors:  A S Cross; D G Wright
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

2.  Cellular localization and substrate specificity of isoelectric forms of human liver neuraminidase activity.

Authors:  J Spaltro; J A Alhadeff
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

3.  PNA-binding glycans are expressed at high levels on horse mature and immature T lymphocytes and a subpopulation of B lymphocytes.

Authors:  Catherine Mérant; Ali Messouak; Jean-Luc Cadoré; Jean-Claude Monier
Journal:  Glycoconj J       Date:  2005-02       Impact factor: 2.916

4.  Freeze-stable sialidase activity in human leucocytes: substrate specificity, inhibitor susceptibility, detergent requirements and subcellular localization.

Authors:  P J Waters; A P Corfield; R Eisenthal; C A Pennock
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

5.  Ganglioside GM3 sialidase activity in fibroblasts of normal individuals and of patients with sialidosis and mucolipidosis IV. Subcellular distribution and and some properties.

Authors:  M Lieser; E Harms; H Kern; G Bach; M Cantz
Journal:  Biochem J       Date:  1989-05-15       Impact factor: 3.857

6.  Genetic analysis of liver neuraminidase isozymes in Rattus norvegicus: independent control of NEU-1 and NEU-2 phenotypes.

Authors:  P B Samollow; J L Vandeberg; A L Ford; H W Kunz; T J Gill
Journal:  Genetics       Date:  1986-09       Impact factor: 4.562

7.  Mucolipidosis I. Roentgenographic follow-up.

Authors:  C R Staalman; H D Bakker
Journal:  Skeletal Radiol       Date:  1984       Impact factor: 2.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.